Roscovitine, a Specific Inhibitor of Cellular Cyclin-Dependent Kinases, Inhibits Herpes Simplex Virus DNA Synthesis in the Presence of Viral Early Proteins
- 1 March 2000
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (5) , 2107-2120
- https://doi.org/10.1128/jvi.74.5.2107-2120.2000
Abstract
We have previously shown that two inhibitors specific for cellular cyclin-dependent kinases (cdks), Roscovitine (Rosco) and Olomoucine (Olo), block the replication of herpes simplex virus (HSV). Based on these results, we demonstrated that HSV replication requires cellular cdks that are sensitive to these drugs (L. M. Schang, J. Phillips, and P. A. Schaffer. J. Virol. 72:5626–5637, 1998). We further established that at least two distinct steps in the viral replication cycle require cdks: transcription of immediate-early (IE) genes and transcription of early (E) genes (L. M. Schang, A. Rosenberg, and P. A. Schaffer, J. Virol. 73:2161–2172, 1999). Since Rosco inhibits HSV replication efficiently even when added to infected cells at 6 h postinfection, we postulated that cdks may also be required for viral functions that occur after E gene expression. In the study presented herein, we tested this hypothesis directly by measuring the efficiency of viral replication, viral DNA synthesis, and expression of several viral genes during infections in which Rosco was added after E proteins had already been synthesized. Rosco inhibited HSV replication, and specifically viral DNA synthesis, when the drug was added at the time of release from a 12-h phosphonoacetic acid (PAA)-induced block in viral DNA synthesis. Inhibition of DNA synthesis was not a consequence of inhibition of expression of IE or E genes in that Rosco had no effect on steady-state levels of two E transcripts under the same conditions in which it inhibited viral DNA synthesis. Moreover, viral DNA synthesis was inhibited by Rosco even in the absence of protein synthesis. In a second series of experiments, the replication of four HSV mutants harboring temperature-sensitive mutations in genes essential for viral DNA replication was inhibited when Rosco was added at the time of shift-down from the nonpermissive to the permissive temperature. Viral DNA synthesis was inhibited by Rosco under these conditions, whereas expression of viral E genes was not affected. We conclude that cellular Rosco-sensitive cdks are required for replication of viral DNA in the presence of viral E proteins. This requirement may indicate that HSV DNA synthesis is functionally linked to transcription, which requires cdks, or that both viral transcription and DNA replication, independently, require viral or cellular factors activated by Rosco-sensitive cdks.Keywords
This publication has 132 references indexed in Scilit:
- Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinasesPublished by Wiley ,2012
- The Cyclin-Dependent Kinase Inhibitors Olomoucine and Roscovitine Arrest Human Fibroblasts in G1 Phase by Specific Inhibition of CDK2 Kinase ActivityExperimental Cell Research, 1998
- Recent advances on cyclins, CDKs and CDK inhibitorsTrends in Cell Biology, 1997
- A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function.Genes & Development, 1997
- Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.Genes & Development, 1996
- Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II.Molecular Biology of the Cell, 1996
- Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.Genes & Development, 1995
- Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitionsFEBS Letters, 1994
- Cyclin A is required in S phase in normal epithelial cellsBiochemical and Biophysical Research Communications, 1992
- The relative stability of selected herpes simplex virus type 1 mRNAsVirus Research, 1991